News
Freshfields advises Mindray on the acquisition of a majority interest in DiaSys
Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) advised Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (‘Mindray’) on the acquisition of a 75% stake in DiaSys Diagnostic Systems GmbH (‘DiaSys’). Mindray is a leading global developer, manufacturer and marketer of medical devices and listed on the Shenzhen stock exchange.
DiaSys is a leading specialist in the development and manufacturing of diagnostic system solutions based in Germany with production facilities across Europe, APAC, and Latin America serving customers in more than 140 countries.
Going forward, Mindray will provide support to DiaSys’ global supply platform and international team of professionals to expedite production localization in foreign markets, support the expansion into large- and medium-volume customer groups worldwide, and offer more timely and comprehensive professional service to clients. At the same time, DiaSys’ extensive experience in clinical chemistry is also expected to bring synergies to Mindray's business.
The Freshfields cross-border team advising Mindray on the transaction was led by partner Olga Stürmer and principal associate Carsten Haak in Germany together with client relationship partner Richard Perks in Hong Kong. The core team also included principal associate Eva-Maria Hoyler, associates Johannes Rogge-Balleer and Agnieszka Chambellan and transaction lawyer Besdegül Ünsal.
Antitrust and foreign investment advice was provided by partner Alastair Mordaunt and counsels Laurent Bougard and Uwe Salaschek, and principal associate Marie-Theres Urban.
Partner Alexander Schwahn, principal associate Tobias Franz and tax manager Marius Gorski advised on tax matters.
The transaction team was further supported by a cross-office team including, in Germany, partners Frank Schaer and Igor Gerber, counsel Philipp Lehmann, principal associates Hendrik Witt, Sarah Kutsche and Tristan Kalenborn, associates Fabian Zöpfchen, Marcel Blumör, Yvonne Wolski, Zahar Qasim and Vladimir Korotkov and senior transaction lawyers Franz Dahl, Panagiotis Rentzeperis, Inna Krushchuk and transaction lawyer Daria Gorbacheva-Fuerstenau, in Austria, counsel Lukas Pomaroli, and associate Isabel Süss, in Japan associates Hironori Shimogishi and Megumi Kawatani, in the United States, counsel Jeremiah Nelson and associates Jackson Myers, Joyce Yeo and Matthew Rublin, in Hong Kong, associate Nathalie Leung and senior paralegal Erica Lee, in Shanghai associate Zhiyuan Gu, and in Beijing counsel Ya Ma.
